Bausch Health Q2 2023 earnings press release filed; results not disclosed in 8-K

Bausch Health Companies Inc.

2023-Q2 EPS reported -$0.48 revenue$4,111,000,000

Company issued a press release on August 3, 2023 for Q2 2023 results.
Exhibit 99.1 is referenced but its text is not provided in this filing.
No specific financial figures, guidance changes, or segment data are stated in the 8-K body.
Investors should refer to the full press release for details.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

Bausch Health Companies Inc. reported financial results for the quarter ended June 30, 2023.

Period: the quarter ended June 30, 2023
Result: reported results

Exact text from the filing

On August 3, 2023, Bausch Health Companies Inc. (the “Company”) issued a press release announcing results of operations for the quarter ended June 30, 2023 and certain other financial information as of and for the quarter ended June 30, 2023.

View on SEC.gov

Browse all earnings releases →

Bausch Health Companies Inc. filing history →

Source: SEC EDGAR

accession 0000885590-23-000025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.